XML 32 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Total Revenue $ 22,526,201 $ 32,637,484
Cost of Goods Sold 20,379,519 25,475,170
Gross Profit 2,146,682 7,162,314
Operating Expenses:    
Selling expenses 2,918,418 2,426,971
General and administrative expenses 6,205,040 4,563,216
Research and development expenses 1,278,331 749,249
Total Operating Expenses 10,401,789 7,739,436
Loss from Operations (8,255,107) (577,122)
Other Income (Expense)    
Gain on modification of earn-out liability 306,077 0
Interest and other income 139,513 73,635
Interest expense (120,903) (18,831)
Fair value adjustment of warrants (901,250) 0
Gain (Loss) on currency transactions (1,469,607) 285,742
Gain (Loss) on sale of fixed assets 27,772 (21,060)
Total Other Income (Expense) (2,018,398) 319,486
Loss Before Income Taxes (10,273,505) (257,636)
Income Tax Benefit (465,145) (297,252)
Net Income (Loss) $ (9,808,360) $ 39,616
Basic Income (Loss) Per Share (in dollars per share) $ (0.46) $ 0.00
Diluted Income (Loss) Per Share (in dollars per share) $ (0.46) $ 0.00
Basic Weighted Average Common Shares Outstanding (in shares) 21,209,118 19,652,277
Diluted Weighted Average Common Shares Outstanding (in shares) 21,209,118 19,667,752